State-level Medicaid coverage indicates whether an individual state includes obesity-indicated GLP-1s (Saxenda, Wegovy, and Zepbound) or Type 2 diabetes-indicated GLP-1s (Ozempic, Mounjaro, and Rybelsus) on its formulary or preferred drug list, including non-preferred or restricted coverage
Over time, this can weaken the integrity of existing strands while impeding new growth
Tap any treatment below to see full details and package pricing
There is no clinical evidence from human studies that BPC-157 at therapeutic doses causes kidney damage
Always consider consulting a healthcare provider before starting or continuing BPC 157 usage 2 5
While supplementing with injections is considered safe in most cases, heres what you should know before you try it